These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30808684)

  • 1. Inhibition of contact-mediated activation of factor XI protects baboons against
    Silasi R; Keshari RS; Lupu C; Van Rensburg WJ; Chaaban H; Regmi G; Shamanaev A; Shatzel JJ; Puy C; Lorentz CU; Tucker EI; Gailani D; Gruber A; McCarty OJT; Lupu F
    Blood Adv; 2019 Feb; 3(4):658-669. PubMed ID: 30808684
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus.
    Silasi R; Keshari RS; Regmi G; Lupu C; Georgescu C; Simmons JH; Wallisch M; Kohs TCL; Shatzel JJ; Olson SR; Lorentz CU; Puy C; Tucker EI; Gailani D; Strickland S; Gruber A; McCarty OJT; Lupu F
    Blood; 2021 Jul; 138(2):178-189. PubMed ID: 33598692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial.
    Lorentz CU; Verbout NG; Wallisch M; Hagen MW; Shatzel JJ; Olson SR; Puy C; Hinds MT; McCarty OJT; Gailani D; Gruber A; Tucker EI
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):799-809. PubMed ID: 30700130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
    Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
    Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.
    Tucker EI; Verbout NG; Leung PY; Hurst S; McCarty OJ; Gailani D; Gruber A
    Blood; 2012 May; 119(20):4762-8. PubMed ID: 22442348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI).
    Puy C; Ngo ATP; Pang J; Keshari RS; Hagen MW; Hinds MT; Gailani D; Gruber A; Lupu F; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1390-1401. PubMed ID: 31242030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
    Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
    Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis.
    Keshari RS; Silasi R; Popescu NI; Georgescu C; Chaaban H; Lupu C; McCarty OJT; Esmon CT; Lupu F
    J Thromb Haemost; 2020 Jan; 18(1):180-190. PubMed ID: 31549765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
    Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
    Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
    Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Ngo ATP; Jordan KR; Mueller PA; Hagen MW; Reitsma SE; Puy C; Revenko AS; Lorentz CU; Tucker EI; Cheng Q; Hinds MT; Fazio S; Monia BP; Gailani D; Gruber A; Tavori H; McCarty OJT
    J Thromb Haemost; 2021 Apr; 19(4):1001-1017. PubMed ID: 33421301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduced form of coagulation factor XI is associated with illness severity and coagulopathy in critically-ill septic patients.
    Mor-Cohen R; Zucker M; Grissom C; Brown SM; Seligsohn U; Campbell RA; Blair AM; Rondina MT
    J Thromb Thrombolysis; 2019 Feb; 47(2):186-191. PubMed ID: 30600428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation.
    Skjeflo EW; Christiansen D; Fure H; Ludviksen JK; Woodruff TM; Espevik T; Nielsen EW; Brekke OL; Mollnes TE
    J Thromb Haemost; 2018 May; 16(5):905-918. PubMed ID: 29437288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.
    Minnema MC; Pajkrt D; Wuillemin WA; Roem D; Bleeker WK; Levi M; van Deventer SJ; Hack CE; ten Cate H
    Blood; 1998 Nov; 92(9):3294-301. PubMed ID: 9787166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock.
    Wuillemin WA; Fijnvandraat K; Derkx BH; Peters M; Vreede W; ten Cate H; Hack CE
    Thromb Haemost; 1995 Dec; 74(6):1436-41. PubMed ID: 8772216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated human platelets induce factor XIIa-mediated contact activation.
    Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
    Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.
    Crosby JR; Marzec U; Revenko AS; Zhao C; Gao D; Matafonov A; Gailani D; MacLeod AR; Tucker EI; Gruber A; Hanson SR; Monia BP
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1670-8. PubMed ID: 23559626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H.
    Puy C; Pang J; Reitsma SE; Lorentz CU; Tucker EI; Gailani D; Gruber A; Lupu F; McCarty OJT
    J Immunol; 2021 Apr; 206(8):1784-1792. PubMed ID: 33811105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic acid inhibits intravascular coagulation during Staphylococcus aureus-induced sepsis in mice.
    Carestia A; Davis RP; Grosjean H; Lau MW; Jenne CN
    Blood; 2020 Apr; 135(15):1281-1286. PubMed ID: 31951648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.